Litigation Details for SUMITOMO DAINIPPON PHARMA CO., LTD. v. PIRAMAL HEALTHCARE UK LIMITED (D.N.J. 2018)
✉ Email this page to a colleague
SUMITOMO DAINIPPON PHARMA CO., LTD. v. PIRAMAL HEALTHCARE UK LIMITED (D.N.J. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-08-31 |
Court | District Court, D. New Jersey | Date Terminated | 2019-11-25 |
Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
Jury Demand | None | Referred To | Cathy L. Waldor |
Parties | SUMITOMO DAINIPPON PHARMA CO., LTD. | ||
Patents | 8,729,085; 8,883,794; 9,174,975; 9,259,423; 9,555,027; 9,815,827; 9,827,242; 9,907,794 | ||
Attorneys | CHARLES H. CHEVALIER | ||
Firms | Stone Conroy LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in SUMITOMO DAINIPPON PHARMA CO., LTD. v. PIRAMAL HEALTHCARE UK LIMITED
Details for SUMITOMO DAINIPPON PHARMA CO., LTD. v. PIRAMAL HEALTHCARE UK LIMITED (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-08-31 | 1 | Complaint | FDA ten patents for Latuda®. The listed patents are U.S. Patent Nos. 5,532,372, 8,729,085, 8,883,794…United States Patent Nos. 9,815,827 (the “’827 patent”) and 9,907,794 (the “’794 patent”) (collectively…the ’827 patent is attached hereto as Exhibit A. A true and accurate copy of the ’794 patent is attached… U.S. Patent No. 9,815,827 25. The ’827 patent, entitled “Agent for Treatment… ’827 patent. 27. Plaintiff Sunovion is the exclusive licensee to the ’827 patent in the | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |